Technology ❯ Biotechnology ❯ mRNA Technology

Vaccine Development

Clinical Trials COVID-19 Vaccines Moderna Curevac Cancer Treatment Health Innovations Public Health Innovations Clinical Research Covid-19 Vaccines mRNA Vaccines Flu Vaccine Medical Applications Cancer Treatments AI in Medicine Scientific Innovation Cancer Vaccines Patent Conflicts

14 ARTICLES

last mo.

FDA Advisers Unanimously Back Moderna’s mRNA Flu Vaccine

Unanimous advisory support advances the shot toward licensure; final FDA action is due by Aug. 5, with CDC coverage unsettled by ACIP’s inability to convene.

7 ARTICLES

2mo ago

HHS Axes $500 Million in BARDA mRNA Vaccine Projects, Drawing Intensifying Warnings

8 ARTICLES

11mo ago

US Cuts $500 Million in mRNA Vaccine Research Funding

5 ARTICLES

last yr.

Moderna’s mRNA-1010 Flu Vaccine Shows Superior Efficacy in Phase 3 Trial

Vaccine Development

FDA Advisers Unanimously Back Moderna’s mRNA Flu Vaccine

Moderna Jumps on Hantavirus Cruise-Ship Cluster as U.S. Repatriates 17 Citizens

Moderna Beats Q1 Forecast as Overseas COVID Shot Sales Rebound

Moderna Begins Phase III Trial of mRNA Bird Flu Vaccine in UK and US

HHS Axes $500 Million in BARDA mRNA Vaccine Projects, Drawing Intensifying Warnings

US Cuts $500 Million in mRNA Vaccine Research Funding

Moderna’s mRNA-1010 Flu Vaccine Shows Superior Efficacy in Phase 3 Trial